Wednesday, June 10, 2026

pharma Β· Asthma Β· Osteoarthritis Β· AMRX

Amneal Pharma Europe

Amneal Pharma Europe clinical programs β€” 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

400 Crossing Boulevard, Bridgewater, New Jersey 08807, US HQ
2002 Founded
7,179 Employees
Public company Type
AMRX Β· NYSE Ticker
Company details
Status
Public
HQ
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
Founded
2002
Employees
7,179
Programs
15
Drugs
210
Patents
32
Intelligence Β· Clinical Programs

Amneal Pharma Europe projects

15 ClinicalTrials.gov programs sponsored by Amneal Pharma Europe.

Amneal Pharma Europe has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AM-PHN-004

    Amneal Pharma Europe Ltd

    Uncomplicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial
  2. Asenapine Sublingual Tablets 10 mg

    Amneal Pharma Europe Ltd

    Schizophrenia

    phase 3 small molecule completed

    1 trial
  3. Diclofenac Sodium Topical Gel, 1%

    Amneal Pharma Europe Ltd

    Osteoarthritis

    phase 3 small molecule completed

    1 trial
  4. Estradiol Vaginal Tablets 10 mcg

    Amneal Pharma Europe Ltd

    Atrophic Vaginitis Due to Menopause

    phase 3 small molecule completed

    1 trial
  5. Imatinib Mesylate Tablets, 400 mg

    Amneal Pharma Europe Ltd

    Chronic Myeloid Leukemia

    phase 3 small molecule completed

    1 trial
  6. Mometasone Furoate Nasal Spray, 50 mcg

    Amneal Pharma Europe Ltd

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial
  7. Phenazopyridine Hydrochloride

    Amneal Pharma Europe Ltd

    Pain

    phase 3 small molecule completed

    1 trial
  8. Placebo

    Amneal Pharma Europe Ltd

    Asthma

    phase 3 small molecule active

    1 trial
  9. Test - Bimatoprost 0.01% Ophthalmic Solution

    Amneal Pharma Europe Ltd

    Glaucoma, Open-Angle

    phase 3 small molecule active

    1 trial
  10. Test Product

    Amneal Pharma Europe Ltd

    Asthma

    phase 3 small molecule active

    2 trials
  11. Testosterone Topical Gel, 1.62% Metered Pump

    Amneal Pharma Europe Ltd

    Primary Hypogonadism

    phase 3 small molecule completed

    1 trial
  12. Bimatoprost Ophthalmic Solution, 0.01%

    Amneal Pharma Europe Ltd

    Open-angle Glaucoma

    phase 1 small molecule active

    1 trial
  13. KSHN001126 150mg

    Amneal Pharma Europe Ltd

    Healthy Postmenopausal Women

    phase 1 small molecule completed

    1 trial
  14. Methotrexate - Amneal

    Amneal Pharma Europe Ltd

    Psoriasis

    phase 1 small molecule active

    1 trial
  15. CREXONT ER

    Amneal Pharma Europe Ltd

    Parkinson Disease

    approved small molecule active

    2 trials

Frequently asked questions

How many clinical projects does Amneal Pharma Europe have?

15 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.